Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms

Late-onset neutropenia following rituximab therapy in rheumatic diseases: Association with B lymphocyte depletion and infections

(2011) Daniel Tesfa et al.   ARTHRITIS AND RHEUMATISM

Rituximab-induced late onset neutropenia in newly-diagnosed B-cell lymphoma correlates with Fc receptor FcγRIIIa 158(V/F) polymorphism

(2010) Szu-Chin Li et al.   AMERICAN JOURNAL OF HEMATOLOGY

Clinical impact and predisposing factors of delayed-onset neutropenia after autologous hematopoietic stem-cell transplantation for B-cell non-Hodgkin lymphoma: association with an incremental risk of infectious events

(2010) H. Kato et al.   ANNALS OF ONCOLOGY

Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry

(2010) J.-E. Gottenberg et al.   ARTHRITIS AND RHEUMATISM

The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases

(2010) Nichola Cooper et al.   BRITISH JOURNAL OF HAEMATOLOGY

Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

(2010) E. P. Rhee et al.   Clinical Journal of the American Society of Nephrology

Rituximab: Mechanism of Action

(2010) George J. Weiner   SEMINARS IN HEMATOLOGY

Idiosyncratic drug-induced agranulocytosis: Possible mechanisms and management

(2009) Daniel Tesfa et al.   AMERICAN JOURNAL OF HEMATOLOGY

Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma

(2009) Gillianne Geet Yi Lai et al.   AMERICAN JOURNAL OF HEMATOLOGY

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis

(2009) Rachel B. Jones et al.   ARTHRITIS AND RHEUMATISM

Late Onset Neutropenia and Immunoglobulin Suppression of the Patients with Malignant Lymphoma Following Autologous Stem Cell Transplantation with Rituximab

(2009) Yasuo Hirayama et al.   INTERNAL MEDICINE

Immunoglobulin G Fc Receptor FcγRIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma

(2009) Wen-Kai Weng et al.   JOURNAL OF CLINICAL ONCOLOGY

The late adverse events of rituximab therapy – rare but there!

(2009) Ron Ram et al.   LEUKEMIA & LYMPHOMA

Rituximab-related late-onset neutropenia in a patient with severe rheumatoid arthritis

(2008) H Marotte et al.   ANNALS OF THE RHEUMATIC DISEASES

Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia

(2008) K Stamatopoulos et al.   LEUKEMIA

Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis

(2008) Daniel Tesfa et al.   MEDICAL ONCOLOGY